LUMINEX CORPORATION Inactive Instrument
Company Luminex Corporation
Equities
LMNX
US55027E1029
Advanced Medical Equipment & Technology
Business Summary
Number of employees: 1,325
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Andrea Giubboni
DFI | Director of Finance/CFO | - | 14/21/14 |
| Chief Tech/Sci/R&D Officer | 47 | 01/06/01 | |
Joern Mosner
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Christine Valle
IRO | Public Communications Contact | - | - |
John Hoffarth
TRE | Treasurer | - | 14/21/14 |
David B. Oldham
PRN | Corporate Officer/Principal | - | 01/08/01 |
Reid Sadler
SAM | Sales & Marketing | - | 01/14/01 |
| Corporate Officer/Principal | - | 01/23/01 | |
Steven Back
LAW | General Counsel | - | 01/08/01 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Andrea Giubboni
DFI | Director of Finance/CFO | - | 14/21/14 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 47,311,982 | 45,251,978 ( 95.65 %) | 0 | 95.65 % |
Company contact information
Luminex Corp.
12212 Technology Boulevard Suite 130
78727, Austin
+512 219 8020
http://www.luminexcorp.com
Group companies
| Name | Category and Sector |
|---|---|
Luminex Molecular Diagnostics, Inc.
 Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. |
Medical/Nursing Services
|
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +8.69% | 219B | |
| +6.69% | 183B | |
| +10.90% | 133B | |
| +25.41% | 108B | |
| +0.27% | 63.06B | |
| +12.72% | 52.02B | |
| +3.96% | 48.2B | |
| +0.40% | 40.37B | |
| +15.03% | 39.35B |
